B-cell lymphoma DNA vaccine (Cancer Research Ventures)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameB-cell lymphoma DNA vaccine (Cancer Research Ventures)
Drug Alias Namemultiple myeloma DNA vaccine (Cancer Research Ventures)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMultiple MyelomaLymphoma, B-CellLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research Ventures Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research Ventures Ltd
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, B-CellLeukemia

Other Information

ATC CodeN/A
Related LinksN/A